GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Interpharm Holdings Inc (GREY:IPAH) » Definitions » Research & Development

Interpharm Holdings (Interpharm Holdings) Research & Development : $17.03 Mil (TTM As of Dec. 2007)


View and export this data going back to 2008. Start your Free Trial

What is Interpharm Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Interpharm Holdings's Research & Development for the three months ended in Dec. 2007 was $2.90 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2007 was $17.03 Mil.

Interpharm Holdings Research & Development Historical Data

The historical data trend for Interpharm Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpharm Holdings Research & Development Chart

Interpharm Holdings Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.54 4.00 10.67 18.96

Interpharm Holdings Quarterly Data
Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.87 4.71 5.96 3.46 2.90

Interpharm Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $17.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interpharm Holdings  (GREY:IPAH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Interpharm Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Interpharm Holdings (Interpharm Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Interpharm Holdings Inc (GREY:IPAH) » Definitions » Research & Development
Comparable Companies
NUVPF ADMD RSPI YBAO ULUR NRXCF ACUR LBLTF PUFXF BKIT RLMD IGC MYOS CBICF SBFM PVCT AQSZF PTLF AOLS APRI
Traded in Other Exchanges
N/A
Address
75 Adams Avenue, Hauppague, NY, USA, 11788
Website
Interpharm Holdings Inc manufactures generic and over-the-counter medications. The company also pursues the development of other generic drugs in broad categories.

Interpharm Holdings (Interpharm Holdings) Headlines

No Headlines